Search results
Katalin "Kati" Karikó (Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American biochemist who specializes in ribonucleic acid -mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy.
Dr. Kariko is a researcher who co-discovered the mRNA technology used in COVID-19 vaccines. She is a senior vice president at BioNTech and an adjunct professor of Neurosurgery at the University of Pennsylvania.
Apr 8, 2021 · Now Katalin Kariko, 66, known to colleagues as Kati, has emerged as one of the heroes of Covid-19 vaccine development. Her work, with her close collaborator, Dr. Drew Weissman of the...
Oct 2, 2023 · Karikó and Weissman discovered how to modify mRNA to avoid inflammatory responses and improve protein production. They faced challenges and setbacks in their career, but their work led to mRNA vaccines against COVID-19.
Oct 2, 2023 · The Penn mRNA vaccine research team is recognized for their foundational discoveries that enabled the development of COVID-19 vaccines. They are the 28th and 29th Nobel laureates affiliated with Penn and the 61st woman to ever receive the prize in Physiology or Medicine.
Oct 30, 2023 · Katalin Karikó is a Hungarian-born biochemist who discovered how to stabilize mRNA for therapeutic applications. She faced challenges and discrimination in academia, but later co-founded BioNTech, the company that developed COVID-19 mRNA vaccines.
People also ask
Did Katalin Karikó and drew Weissman win a Nobel Prize?
Why is Katalin Karikó important?
When was Katalin Karikó's autobiography published?
Where did Katalin Karikó donate her Nobel Prize?
Katalin Karikó. BioNTech RNA Pharmaceuticals. Verified email at upenn.edu. mRNA-based therapy for protein replacement.
